IRUS-ANZ has moved. From January 2022, new monthly statistics will only be added to the IRUS R5 service. This site is archived. All statistics up to December 2021 will remain available on this site.

Item Statistics

Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab

RepositoryVictoria University [Research Repository]
URLhttps://vuir.vu.edu.au/42589/
Author(s)Florou, Despoina; Katsara, M; Feehan, Jack; Dardiotis, Efthimios; Apostolopoulos, Vasso
Item typeArticle
DOIhttps://doi.org/10.3390/brainsci10100758

Sorry - we've not seen any usage for this item in the last six weeks...

Jisc logo Cranfield logo CAVAL logo